Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.39% |
| 2 | Financials | 6.67% |
| 3 | Healthcare | 6.18% |
| 4 | Industrials | 4.97% |
| 5 | Consumer Discretionary | 4.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TCFC
3926
DELISTED
The Community Financial Corporation Common Stock
TCFC
| $1.93M | ﹤0.01% |
52,318
-28,832
| -36% | -$1.03M |
|
3927
SAB Biotherapeutics
SABS
$298M
| $1.93M | ﹤0.01% |
19,131
+15,465
| +422% | +$1.54M |
|
3928
CALL
Glaukos
GKOS
$10.1B
| $1.93M | ﹤0.01% |
40,000
+25,000
| +167% | +$1.39M |
|
|
HIIIU
3929
DELISTED
Hudson Executive Investment Corp. III Unit
HIIIU
| $1.93M | ﹤0.01% |
195,657
-689,134
| -78% | -$6.83M |
|
3930
Algonquin Power & Utilities
AQN
$4.42B
| $1.92M | ﹤0.01% |
131,071
-55,221
| -30% | -$852K |
|
|
HCCC
3931
DELISTED
Healthcare Capital Corp. Class A common stock
HCCC
| $1.92M | ﹤0.01% |
194,858
+179,858
| +1,199% | +$1.77M |
|
|
OCAX
3932
DELISTED
OCA Acquisition Corp. Class A Common Stock
OCAX
| $1.92M | ﹤0.01% |
193,827
-30,173
| -13% | -$297K |
|
3933
Autoliv
ALV
$9.03B
| $1.92M | ﹤0.01% |
22,374
-88,535
| -80% | -$8.17M |
|
3934
PUT
VanEck Junior Gold Miners ETF
GDXJ
$7.3B
| $1.92M | ﹤0.01% |
50,000
| – | – |
|
3935
Mitsubishi UFJ Financial
MUFG
$247B
| $1.92M | ﹤0.01% |
323,285
+304,985
| +1,667% | +$1.69M |
|
3936
AEON Biopharma
AEON
$12.6M
| $1.92M | ﹤0.01% |
2,732
+1,444
| +112% | +$1.01M |
|
3937
Madrigal Pharmaceuticals
MDGL
$11.6B
| $1.92M | ﹤0.01% |
24,019
-21,864
| -48% | -$1.89M |
|
3938
RPC Inc
RES
$1.29B
| $1.92M | ﹤0.01% |
394,005
-198,926
| -34% | -$832K |
|
|
CFIV
3939
DELISTED
CF Acquisition Corp. IV Class A common stock
CFIV
| $1.92M | ﹤0.01% |
196,854
+54,267
| +38% | +$527K |
|
3940
Adeia
ADEA
$3.35B
| $1.91M | ﹤0.01% |
383,984
+204,767
| +114% | +$1.1M |
|
|
SHACU
3941
DELISTED
SCP & CO Healthcare Acquisition Company Unit
SHACU
| $1.91M | ﹤0.01% |
192,000
-493,412
| -72% | -$4.94M |
|
3942
NetApp
NTAP
$37.4B
| $1.91M | ﹤0.01% |
21,285
-282,831
| -93% | -$23.9M |
|
3943
PUT
Stellantis
STLA
$21.7B
| $1.91M | ﹤0.01% |
100,000
| – | – |
|
3944
ACI Worldwide
ACIW
$5.78B
| $1.91M | ﹤0.01% |
62,128
+8,291
| +15% | +$275K |
|
|
AMAM
3945
DELISTED
Ambrx Biopharma Inc
AMAM
| $1.91M | ﹤0.01% |
141,431
-2,661
| -2% | -$47.9K |
|
3946
CALL
Boston Properties
BXP
$11.2B
| $1.91M | ﹤0.01% |
17,600
-32,400
| -65% | -$3.7M |
|
3947
AdvanSix
ASIX
$537M
| $1.91M | ﹤0.01% |
47,942
-77,910
| -62% | -$2.68M |
|
3948
CALL
eBay
EBAY
$48.3B
| $1.9M | ﹤0.01% |
27,300
-348,000
| -93% | -$24.9M |
|
3949
US Foods
USFD
$21.8B
| $1.9M | ﹤0.01% |
54,848
-210,953
| -79% | -$7.24M |
|
|
GTY
3950
Getty Realty Corp
GTY
$2.08B
| $1.9M | ﹤0.01% |
64,770
-29,305
| -31% | -$915K |
|
Similar funds
Millennium Management's Q3 2021 Portfolio in Review
As of Q3 2021, Millennium Management held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Millennium Management deployed $8.65B of net new capital in Q3 2021, opening 1,244 new positions and adding to 2,720 existing holdings. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M.
By sector, the portfolio is most concentrated in Technology at 7.4% of assets, down from 7.8% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $694M trimmed.
- Millennium Management's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Millennium Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Millennium Management's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Millennium Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Millennium Management's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Millennium Management opened 1,244 new positions and closed 981 in Q3 2021.
- Millennium Management's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.